| Authors: |
Ferguson M; Colchester Research Group, 68 Robie, Truro, NS B2N 1L2, Canada., Murray A; PharmQuest, 806 Green Valley Rd Ste 305, Greensboro, NC 27408, United States., Pliamm L; Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group, 2 Champagne Dr, Toronto, ON M3J 0K2, Canada., Rombo L; Clinical Research Centre Sörmland, Eskilstuna SE-631 88, Sweden.; Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala SE-751 05, Sweden., Sanmartin Berglund J; Department of Health, Blekinge Institute of Technology, Valhallavägen 1, Karlskrona SE-371 79, Sweden.; Department of Clinical Sciences, Lund University, BMC I12, Lund SE-221 84, Sweden., David MP; GSK, Avenue Fleming 20, Wavre 1300, Belgium., De Schrevel N; GSK, Rue de l'Institut 89, Rixensart 1330, Belgium., Maschino F; GSK, Avenue Fleming 20, Wavre 1300, Belgium., Kotb S; GSK, Avenue Fleming 20, Wavre 1300, Belgium., Olivier A; GSK, Avenue Fleming 20, Wavre 1300, Belgium., Hulstrøm V; GSK, Avenue Fleming 20, Wavre 1300, Belgium. |
